LAPSE:2023.11238
Published Article

LAPSE:2023.11238
Exopolysaccharides of Fungal Origin: Properties and Pharmaceutical Applications
February 27, 2023
Abstract
Fungal exopolysaccharides (EPSs) represent an important group of bioactive compounds secreted by fungi. These biopolymers can be utilized individually or in combination with different bioactive substances for a broad range of pharmaceutical field applications, due to their various biological activities, such as antioxidant, antimicrobial, anti-inflammatory, antiviral, anti-diabetic, and anticoagulant effects. The paper presents an up-to-date review of the main fungal polysaccharides (pullulan, schizophyllan, scleroglucan, botryosphaeran, lentinan, grifolan, and lasiodiplodan), highlighting their structures, producing strains, and useful properties in a double position, as controlled release (rate and selectively targeting) drug carriers, but mostly as active immunomodulating and antitumor compounds in cancer therapy.
Fungal exopolysaccharides (EPSs) represent an important group of bioactive compounds secreted by fungi. These biopolymers can be utilized individually or in combination with different bioactive substances for a broad range of pharmaceutical field applications, due to their various biological activities, such as antioxidant, antimicrobial, anti-inflammatory, antiviral, anti-diabetic, and anticoagulant effects. The paper presents an up-to-date review of the main fungal polysaccharides (pullulan, schizophyllan, scleroglucan, botryosphaeran, lentinan, grifolan, and lasiodiplodan), highlighting their structures, producing strains, and useful properties in a double position, as controlled release (rate and selectively targeting) drug carriers, but mostly as active immunomodulating and antitumor compounds in cancer therapy.
Record ID
Keywords
applications, bioprocesses, exopolysaccharides, filamentous fungi, pharmaceutical properties
Subject
Suggested Citation
Stoica RM, Moscovici M, Lakatos ES, Cioca LI. Exopolysaccharides of Fungal Origin: Properties and Pharmaceutical Applications. (2023). LAPSE:2023.11238
Author Affiliations
Stoica RM: National Institute for Chemical-Pharmaceutical Research and Development-ICCF Bucharest, Vitan Avenue 112, District 3, 031299 Bucharest, Romania
Moscovici M: National Institute for Chemical-Pharmaceutical Research and Development-ICCF Bucharest, Vitan Avenue 112, District 3, 031299 Bucharest, Romania
Lakatos ES: Institute for Research in Circular Economy and Environment “Ernest Lupan”, 400609 Cluj-Napoca, Romania; Faculty of Industrial Engineering, Robotics and Product Management, Technical University of Cluj-Napoca, 400641 Cluj-Napoca, Romania [ORCID]
Cioca LI: Industrial Engineering and Management Department, Faculty of Engineering, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania [ORCID]
Moscovici M: National Institute for Chemical-Pharmaceutical Research and Development-ICCF Bucharest, Vitan Avenue 112, District 3, 031299 Bucharest, Romania
Lakatos ES: Institute for Research in Circular Economy and Environment “Ernest Lupan”, 400609 Cluj-Napoca, Romania; Faculty of Industrial Engineering, Robotics and Product Management, Technical University of Cluj-Napoca, 400641 Cluj-Napoca, Romania [ORCID]
Cioca LI: Industrial Engineering and Management Department, Faculty of Engineering, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania [ORCID]
Journal Name
Processes
Volume
11
Issue
2
First Page
335
Year
2023
Publication Date
2023-01-20
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr11020335, Publication Type: Review
Record Map
Published Article

LAPSE:2023.11238
This Record
External Link

https://doi.org/10.3390/pr11020335
Publisher Version
Download
Meta
Record Statistics
Record Views
386
Version History
[v1] (Original Submission)
Feb 27, 2023
Verified by curator on
Feb 27, 2023
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2023.11238
Record Owner
Auto Uploader for LAPSE
Links to Related Works
(0.07 seconds)
[0.08 s]
